Search research articles
Contact Us
Filters
Showing results (251-260 of 281) with videos related to
Page
of 29
Sort By:
Molecular Immunology
|
February 1, 1996
Cloning and characterization of a new allergen, Mag 3, from the house dust mite, Dermatophagoides farinae: cross-reactivity with high-molecular-weight allergen
A Fujikawa, N Ishimaru, A Seto, et al.
Microbiology and Immunology
|
January 1, 1997
Thiadiazole derivatives: highly potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) replications in vitro
M Fujiwara, K Ijichi, Y Hanasaki, et al.
Journal of Medicinal Chemistry
|
April 1, 1991
Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)
H Tanaka, M Baba, M Ubasawa, et al.
Journal of Medicinal Chemistry
|
July 21, 1995
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents
H Tanaka, H Takashima, M Ubasawa, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1994
Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro
M Baba, S Shigeta, S Yuasa, et al.
Antiviral Chemistry & Chemotherapy
|
September 10, 1999
Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro
S Shigeta, S Mori, T Kira, et al.
Reviews of Infectious Diseases
|
July 1, 1989
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations
C S Rabkin, W R Jarvis, R L Anderson, et al.
Antiviral Research
|
August 26, 1998
RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses
M Fujiwara, N Ashida, M Okamoto, et al.
Antiviral Chemistry & Chemotherapy
|
January 11, 2000
Characterization of human immunodeficiency virus type 1 strains resistant to the non-nucleoside reverse transcriptase inhibitor RD4-2217
M Fujiwara, E N Kodama, M Okamoto, et al.
Oncogene
|
September 15, 2015
Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid
K Kitatani, T Usui, S K Sriraman, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 281) with videos related to
Sort By:
Page
of 29
Molecular Immunology
|
February 1, 1996
Cloning and characterization of a new allergen, Mag 3, from the house dust mite, Dermatophagoides farinae: cross-reactivity with high-molecular-weight allergen
A Fujikawa, N Ishimaru, A Seto, et al.
Microbiology and Immunology
|
January 1, 1997
Thiadiazole derivatives: highly potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) replications in vitro
M Fujiwara, K Ijichi, Y Hanasaki, et al.
Journal of Medicinal Chemistry
|
April 1, 1991
Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)
H Tanaka, M Baba, M Ubasawa, et al.
Journal of Medicinal Chemistry
|
July 21, 1995
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents
H Tanaka, H Takashima, M Ubasawa, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1994
Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro
M Baba, S Shigeta, S Yuasa, et al.
Antiviral Chemistry & Chemotherapy
|
September 10, 1999
Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro
S Shigeta, S Mori, T Kira, et al.
Reviews of Infectious Diseases
|
July 1, 1989
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations
C S Rabkin, W R Jarvis, R L Anderson, et al.
Antiviral Research
|
August 26, 1998
RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses
M Fujiwara, N Ashida, M Okamoto, et al.
Antiviral Chemistry & Chemotherapy
|
January 11, 2000
Characterization of human immunodeficiency virus type 1 strains resistant to the non-nucleoside reverse transcriptase inhibitor RD4-2217
M Fujiwara, E N Kodama, M Okamoto, et al.
Oncogene
|
September 15, 2015
Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid
K Kitatani, T Usui, S K Sriraman, et al.
Page
of 29